Vivani Medical, Inc.
Qualité des données : 83%
VANI
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
1,04 €
0,00 €
(0,00%)
Cap. Boursière: 87,61 M
Prix
1,04 €
Cap. Boursière
87,61 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Negative free cash flow of -25,49 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-855,73%
En dessous de la moyenne du secteur (-53,41%)
ROIC-107,76%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current Ratio0,61
Interest CoverageN/A
Valorisation
PE (TTM)
-3,29
En dessous de la moyenne du secteur (-1,48)
P/B Ratio66,93
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,3 | -1,5 |
| P/B | 66,9 | 1,6 |
| ROE % | -855,7 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -26,61 M |
| ROE | -855,73% | ROA | -98,64% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -25,49 M |
| ROIC | -107,76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,61 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2,66 M | Tangible Book Value | 1,31 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,29 | Forward P/E | N/A |
| P/B Ratio | 66,93 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -29,10% | ||
| Market Cap | 87,61 M | Enterprise Value | 84,98 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,43 | Revenue / Share | N/A |
| FCF / Share | -0,30 | OCF / Share | -0,29 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 95,81% |
| SBC-Adj. FCF | -26,98 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -26,61 M | -23,49 M | -25,65 M | -13,89 M | -8,92 M |
| EPS (Diluted) | -0,43 | -0,43 | — | — | — |
| Gross Profit | — | — | — | — | 130 000,0 |
| Operating Income | -27,56 M | -24,68 M | -26,97 M | -21,24 M | -8,93 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 18,13 M | 15,75 M | 16,97 M | 14,17 M | 2,37 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 424 000,0 | 400 000,0 | 357 000,0 | 381 000,0 | 70 000,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 2 000,0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 39,39 M | 41,56 M | 45,80 M | 51,13 M | 70,88 M |
| Total Liabilities | 23,66 M | 23,95 M | 25,04 M | 6,82 M | 2,51 M |
| Shareholders' Equity | 15,73 M | 17,61 M | 20,76 M | 44,31 M | 68,37 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 16,23 M | 18,35 M | 20,65 M | — | 69,59 M |
| Current Assets | 17,90 M | 20,44 M | 23,06 M | 47,53 M | 70,51 M |
| Current Liabilities | 6,60 M | 5,99 M | 5,72 M | 6,82 M | 2,46 M |
{"event":"ticker_viewed","properties":{"ticker":"VANI","listing_kind":"stock","pathname":"/stocks/vani","exchange":"Nasdaq","country":"US"}}